Barclays PLC Eyenovia, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.52 - $1.06 $10,649 - $21,708	-20,480 Reduced 91.81%	1,827 $1,000
Q1 2024 May 15, 2024	SELL	$0.99 - $2.37 $18,892 - $45,226	-19,083 Reduced 46.11%	22,307 $22,000
Q4 2023 Feb 15, 2024	BUY	$1.08 - $2.08 $38,849 - $74,821	35,972 Added 663.94%	41,390 $86,000
Q3 2023 Nov 07, 2023	SELL	$1.57 - $2.54 $260 - $421	-166 Reduced 2.97%	5,418 $9,000
Q2 2023 Aug 03, 2023	BUY	$2.21 - $5.75 $12,340 - $32,108	5,584 New	5,584 $13,000
Q2 2021 Aug 13, 2021	SELL	$4.36 - $5.75 $2,454 - $3,237	-563 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.11 - $7.41 $2,876 - $4,171	563 New	563 $3,000
Q3 2020 Nov 12, 2020	SELL	$2.61 - $5.1 $2 - $5	-1 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$2.6 - $3.81 $2 - $3	1 New	1 $0
Q4 2019 Feb 10, 2020	SELL	$2.67 - $4.48 $24 - $40	-9 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.55 - $4.91 $22 - $44	9 New	9 $0

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.42M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.